tiprankstipranks
Trending News
More News >
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market

BioMark Diagnostics (BUX) Financial Statements

Compare
3 Followers

BioMark Diagnostics Financial Overview

BioMark Diagnostics's market cap is currently C$63.05M. The company's EPS TTM is C$-0.004; its P/E ratio is -32.47; BioMark Diagnostics is scheduled to report earnings on March 2, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 22Jun 21Mar 21Mar 20
Income Statement
Total RevenueC$ 154.22KC$ 153.49KC$ 43.93KC$ 0.00C$ 263.28K
Gross ProfitC$ 154.22KC$ -232.70KC$ 43.93KC$ -13.69KC$ 263.28K
Operating IncomeC$ -1.91MC$ -1.84MC$ -1.28MC$ -1.09MC$ -1.18M
EBITDAC$ -1.46MC$ -1.35MC$ -1.22MC$ -1.08MC$ -1.20M
Net IncomeC$ -1.93MC$ -1.84MC$ -1.45MC$ -1.09MC$ -1.22M
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.48MC$ 72.04KC$ 382.71KC$ 877.68KC$ 611.80K
Total AssetsC$ 3.13MC$ 732.29KC$ 1.47MC$ 952.94KC$ 637.29K
Total DebtC$ 454.16KC$ 823.87KC$ 1.05MC$ 119.32KC$ 8.66K
Net DebtC$ -2.03MC$ 751.83KC$ 666.69KC$ -758.35KC$ -603.14K
Total LiabilitiesC$ 1.39MC$ 1.88MC$ 2.11MC$ 1.03MC$ 1.08M
Stockholders' EquityC$ 1.74MC$ -1.15MC$ -635.69KC$ -79.09KC$ -439.13K
Cash Flow
Free Cash FlowC$ -1.10MC$ -919.72KC$ -1.26MC$ -455.55KC$ -454.57K
Operating Cash FlowC$ -1.09MC$ -914.42KC$ -1.20MC$ -455.55KC$ -453.79K
Investing Cash FlowC$ -3.53KC$ -5.30KC$ -59.20KC$ -3.20KC$ -790.00
Financing Cash FlowC$ 3.42MC$ 609.05KC$ 768.16KC$ 724.63KC$ 1.05M
Currency in CAD

BioMark Diagnostics Earnings and Revenue History

BioMark Diagnostics Debt to Assets

BioMark Diagnostics Cash Flow

BioMark Diagnostics Forecast EPS vs Actual EPS